An Open-Label, Randomized, Controlled Clinical Trial to Explore the Curative Effects Between the Treatment of Capecitabine and Andrographolide and the Single Capecitabine in the Patients with Pathological And/Or Histologic Diagnosed Unresectable, Advanced, Recurrent, and Metastatic Colorectal Cancer.
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined